Yahoo Web Search

  1. People widely assume that probiotics and prebiotics are safe, but researchers in France said Monday that there’s very little research to show that’s true. There’s also sparse data ...

  2. About BioArctic AB BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease modifying treatments and reliable biomarkers and diagnostics for neurodegenerative ...

  3. Crescenz Veterans Affairs Medical Center (CMCVAMC) Parkinson's Disease Research Education and Clinical Center (PADRECC) and supported by The Michael J. Fox Foundation for ...

  4. ACAD, +7.65% recently announced FDA approval of a new capsule dose formulation and a new tablet strength of NUPLAZID (pimavanserin) to help in the treatment of patients living with hallucinations ...

  5. Researchers from the University of Liverpool have identified a new compound that protects against neurodegeneration in nematode worms. The discovery may enable novel treatments for human ...

  6. "And the doctor said, 'You have Parkinson's disease.' He said, 'The good news is that you have 10 years of work left.'" Fox was 29 when he was diagnosed with Parkinson ...

  7. Lead researcher Prof Neil Pearce, from LSHTM, said: "We know...persuasive evidence of the long-term effects on cognitive function from professional football." News of the latest ...

  8. Neuroscience drug discoverer Verge Genomics has raised $32 million in early venture capital financing, a large boost to its plans to bring its AI-generated compounds to the clinic against amyotrophic ...

  9. In conjunction with this launch, Neuraly has raised a Series A financing of $36 million from holding company, D&D Pharmatech with participation by major Korean venture funds, including: Smilegate ...

  10. Developing new drugs is a challenging enterprise. It costs pharmaceutical companies an average of $2.7 billion to bring medicine to store shelves, according to the Tufts Center for the Study ...

  1. 1234569 results